Stocktoria
Enlivex Ltd. ENLV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-07-30
Enlivex Ltd. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | 53.1% | -54.2% | -78.9% | -45.9% | -15.2% |
| Return on equity | 63.9% | -63.6% | -96.6% | -54.6% | -17.0% |
| Current ratio | 193.24 | 6.84 | 5.57 | 7.92 | 18.32 |
Source: SEC EDGAR filings · CIK 0001596812 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.